Insider · CIK 0001480111
Stephen K Doberstein
Files at FBRX (Forte Biosciences, Inc.). First filing -, latest -.
In brief
Stephen K Doberstein files SEC Form 4 as director at FBRX (Forte Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stephen K Doberstein has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -2,000 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -1,000 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -1,000 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -2,000 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -31,000 | - | - | 0 | Aug 27, 2026 |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -18,353 | - | - | 0 | Aug 27, 2026 |
| May 29, 2026 | FBRX Forte Biosciences, Inc. | AGrant or award Restricted Stock Unitsderivative | +18,353 | $0.00 | $0 | 18,353 | Jun 2, 2026 |
| Mar 20, 2025 | FBRX Forte Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Mar 21, 2025 |
Questions about Stephen K Doberstein
Answered from the filings on this page, as of the latest one.
Is Stephen K Doberstein buying or selling?
Stephen K Doberstein has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stephen K Doberstein's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen K Doberstein has 0.
Where does Stephen K Doberstein file Form 4?
Stephen K Doberstein has filed Form 4 at FBRX (Forte Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.